# EDGAR Filing Document

**Accession Number:** 0001460702
**File Stem:** 0001493152-25-026593
**Filing Date:** 2025-12
**Character Count:** 2819
**Document Hash:** e6c4d85cb3d40d5b4fbf2c4aca5fb7c5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-026593.hdr.sgml**: 20251208

**ACCESSION NUMBER**: 0001493152-25-026593

**CONFORMED SUBMISSION TYPE**: DEL AM

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251208

**DATE AS OF CHANGE**: 20251208

**EFFECTIVENESS DATE**: 20251208

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AIxCrypto Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001460702
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 263474527
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEL AM
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291926
- **FILM NUMBER:** 251555584

**BUSINESS ADDRESS:**
- **STREET 1:** 2042 CORTE DEL NOGAL
- **STREET 2:** CARLSBAD
- **CITY:** CALIFORNIA
- **STATE:** CA
- **ZIP:** 92011
- **BUSINESS PHONE:** (760) 918-9165

**MAIL ADDRESS:**
- **STREET 1:** 2042 CORTE DEL NOGAL
- **STREET 2:** CARLSBAD
- **CITY:** CALIFORNIA
- **STATE:** CA
- **ZIP:** 92011

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Qualigen Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20200526

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** RITTER PHARMACEUTICALS INC
- **DATE OF NAME CHANGE:** 20090402

![](formdelam_001.jpg)

December 8, 2025

**<u>Via EDGAR</u>**

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Re: AIxCrypto Holdings, Inc. <br> *Registration Statement on Form S-1* <br> *(File No. 333-291926) filed on December 4, 2025*

To Whom It May Concern:

Reference is made to the Registration Statement on Form S-1 (File No. 333-291926) filed by AIxCrypto Holdings, Inc. (the "Issuer") on December 4, 2025 (the "Registration Statement").

Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the "Act"), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the facing page of the Registration Statement immediately following the calculation of registration fee table:

"**The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the SEC, acting pursuant to said Section 8(a) may determine."**

Should you have any questions regarding the Registration Statement, please feel free to contact Peter Campitiello, counsel to the Issuer at (732) 395-4517.

Very truly yours,

*/s/ Kevin A. Richardson II*

Co-Chief Executive Officer

AIxCrpto Holdings, Inc.

cc: Peter Campitiello, Esq.